Adverse Pregnancy Outcomes Among HIV-positive Women in the Era of Universal Antiretroviral Therapy Remain Elevated Compared With HIV-negative WomenVincent Tukei, Appolinaire Tiam, Majoalane Mokone et al.|The Pediatric Infectious Disease Journal|2021Cited by 68
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom et al.|Clinical Infectious Diseases|2023Cited by 23
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, H Appoyer, Lene Ryom et al.|Clinical Infectious Diseases|2020Cited by 22
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elżbieta Bąkowska et al.|Cancers|2023Cited by 19
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort SettingLauren Greenberg, A Tavelli, Lene Ryom et al.|Open Forum Infectious Diseases|2022Cited by 5